Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[PET/CT in lymphoma patients].

H C Steinert1

  • 1Klinik und Poliklinik für Nuklearmedizin, Universitätsspital Zürich, Schweiz. hans.steinert@usz.ch

Der Radiologe
|November 2, 2004
PubMed
Summary
This summary is machine-generated.

Positron emission tomography/computed tomography (PET/CT) is effective for staging and restaging lymphoma. This imaging technique offers higher sensitivity and specificity than contrast-enhanced CT for Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Accuracy of CT parameters for assessment of tumour size and aggressiveness in lung adenocarcinoma with bronchoalveolar elements.

The British journal of radiology·2010
Same author

Lung cancer.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2007
Same author

Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG-PET/CT imaging findings.

European journal of nuclear medicine and molecular imaging·2007
Same author

Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging.

Lung cancer (Amsterdam, Netherlands)·2005
Same author

Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable non-small-cell lung cancer.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2003
Same author

[The impact of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) on planning of radiotherapy].

Terapevticheskii arkhiv·2002

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Lymphoma diagnosis and staging are critical for effective treatment.
  • Accurate assessment of disease extent and response to therapy is essential.
  • Traditional imaging modalities have limitations in sensitivity and specificity.

Purpose of the Study:

  • To report the initial findings of PET/CT in patients with Hodgkin's disease (HD) and aggressive non-Hodgkin's lymphoma (NHL).
  • To evaluate the utility of PET/CT in primary staging, restaging after therapy, and diagnosis of recurrence in lymphoma patients.

Main Methods:

  • A total of 822 PET/CT scans were performed between March 2001 and August 2004.
  • Non-contrast-enhanced low-dose CT was utilized for coregistration with PET.

Related Experiment Videos

  • PET/CT was employed for primary staging, restaging, and recurrence diagnosis in lymphoma patients.

    • Main Results:

    • PET/CT provides exact anatomic localization of (18)F-FDG accumulating lesions, avoiding equivocal or false-positive findings.
    • Compared to contrast-enhanced CT, PET/CT demonstrates higher sensitivity and specificity in patients with HD and aggressive NHL.
    • Integration of PET/CT into radiation therapy planning optimizes the radiation field volume.

    Conclusions:

    • PET/CT has demonstrated significant utility in the staging and restaging of lymphoma, even in the early stages of clinical evaluation.
    • Precise reporting, radiation therapy planning, and surgical biopsy planning are enhanced by the exact anatomic localization provided by PET/CT findings.